These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Saterinone, dobutamine, and sodium nitroprusside: comparison of cardiovascular profiles in patients with congestive heart failure. Kieback AG; Iven H; Stolzenburg K; Baumann G J Cardiovasc Pharmacol; 1998 Oct; 32(4):629-36. PubMed ID: 9781932 [TBL] [Abstract][Full Text] [Related]
28. Prazosin and congestive heart failure: short- and long-term therapy. Rouleau JL; Warnica JW; Burgess JH Am J Med; 1981 Jul; 71(1):147-52. PubMed ID: 7246572 [TBL] [Abstract][Full Text] [Related]
29. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774 [TBL] [Abstract][Full Text] [Related]
30. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function. Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070 [TBL] [Abstract][Full Text] [Related]
31. Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study. Pacher R; Globits S; Wutte M; Rödler S; Heinz G; Kreiner G; Radosztics S; Berger R; Presch I; Weber H Crit Care Med; 1994 Jul; 22(7):1084-90. PubMed ID: 8026195 [TBL] [Abstract][Full Text] [Related]
32. Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure. Packer M; Medina N; Yushak M J Am Coll Cardiol; 1986 Mar; 7(3):671-80. PubMed ID: 2869077 [TBL] [Abstract][Full Text] [Related]
33. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin. Sharpe DN; Coxon R Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361 [TBL] [Abstract][Full Text] [Related]
34. Hemodynamic effects of vasodilators and long-term response in heart failure. Franciosa JA; Dunkman WB; Leddy CL J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522 [TBL] [Abstract][Full Text] [Related]
36. Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure. Stein L; Henry DP; Weinberger MH Am J Med; 1981 Apr; 70(4):825-32. PubMed ID: 7011023 [TBL] [Abstract][Full Text] [Related]
37. [Chronic use of vasodilators in the therapy of congestive cardiac insufficiency]. Manfrin M; Frascione P; Budini A; Cesari GP; Colonna PL; Schicchi F; Chiesa R Minerva Med; 1982 Oct; 73(40):2741-4. PubMed ID: 7133486 [No Abstract] [Full Text] [Related]
38. [Use of peripheral vasodilators with different mechanisms of action in treating heart failure patients]. Novikov SV; Mareev VIu; Elizarova NA; Naumov VG; Sazonova LN Ter Arkh; 1987; 59(9):126-30. PubMed ID: 3424177 [TBL] [Abstract][Full Text] [Related]
39. Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure. Armstrong PW Can Med Assoc J; 1979 Oct; 121(7):913-8. PubMed ID: 497982 [TBL] [Abstract][Full Text] [Related]
40. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin. Awan NA; Beattie JM; Evenson ME; Needham KE; Mason DT J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S176-80. PubMed ID: 6175836 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]